OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glial and myeloid heterogeneity in the brain tumour microenvironment
Brian M. Andersen, Camilo Faust Akl, Michael A. Wheeler, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 12, pp. 786-802
Open Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

Immune checkpoint therapy—current perspectives and future directions
Padmanee Sharma, Sangeeta Goswami, Deblina Raychaudhuri, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1652-1669
Closed Access | Times Cited: 360

Therapeutic targeting of tumour myeloid cells
Simon T. Barry, Dmitry I. Gabrilovich, Owen J. Sansom, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 216-237
Closed Access | Times Cited: 131

Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression
Anirudh Sattiraju, Sang Jo Kang, Bruno Giotti, et al.
Immunity (2023) Vol. 56, Iss. 8, pp. 1825-1843.e6
Open Access | Times Cited: 90

Harmonized single-cell landscape, intercellular crosstalk and tumor architecture of glioblastoma
Cristian Ruiz-Moreno, Sergio Marco Salas, Erik Samuelsson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 74

Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas
Yanming Ren, Zongyao Huang, Lingling Zhou, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 72

CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment
Jiachen Wen, Siyuan Wang, Rongxian Guo, et al.
European Journal of Medicinal Chemistry (2022) Vol. 245, pp. 114884-114884
Closed Access | Times Cited: 66

Tumor-Associated Macrophages in Gliomas—Basic Insights and Treatment Opportunities
Johannes K. Andersen, Hrvoje Miletić, Jubayer A. Hossain
Cancers (2022) Vol. 14, Iss. 5, pp. 1319-1319
Open Access | Times Cited: 64

The local microenvironment drives activation of neutrophils in human brain tumors
Roeltje R. Maas, Klara Soukup, Nadine Fournier, et al.
Cell (2023) Vol. 186, Iss. 21, pp. 4546-4566.e27
Open Access | Times Cited: 61

Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for glioma
Haofei Liu, Qiwen Zhao, Leyong Tan, et al.
Cancer Cell (2023) Vol. 41, Iss. 4, pp. 693-710.e8
Open Access | Times Cited: 54

Brain macrophage development, diversity and dysregulation in health and disease
Aymeric Silvin, Jiawen Qian, Florent Ginhoux
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 11, pp. 1277-1289
Open Access | Times Cited: 50

Harnessing innate immune pathways for therapeutic advancement in cancer
An-Kang Hu, Li Sun, Hao Lin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 24

The Role of Microglia in Brain Metastases: Mechanisms and Strategies
Ying Feng, Xueqing Hu, Yingru Zhang, et al.
Aging and Disease (2024) Vol. 15, Iss. 1, pp. 169-169
Open Access | Times Cited: 16

Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis
Andrew E. Whiteley, Danhui Ma, Lihua Wang, et al.
Science (2024) Vol. 384, Iss. 6702
Closed Access | Times Cited: 11

Glioblastoma upregulates SUMOylation of hnRNP A2/B1 to eliminate the tumor suppressor miR-204-3p, accelerating angiogenesis under hypoxia
Qindong Guo, Fan Yang, Qingtong Wang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 23

Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow–Derived Macrophages
Min Wu, Lingxiang Wu, Wei Wu, et al.
Cancer Research (2023) Vol. 83, Iss. 5, pp. 771-785
Open Access | Times Cited: 21

Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy
Tatiana A. Mishchenko, Victoria D. Turubanova, Ekaterina N. Gorshkova, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 9

Glioma-associated macrophages: unraveling their dual role in the microenvironment and therapeutic implications
Jiachen Wang, Shenglan Li, Yanjie Lan, et al.
Current Medicine (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 7

The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context
Tzu-Yi Chia, Leah K. Billingham, Lauren Boland, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 6

Chimeric Antigen Receptor T Cell and Chimeric Antigen Receptor NK Cell Therapy in Pediatric and Adult High-Grade Glioma—Recent Advances
Adrian Kowalczyk, Julia Zarychta, Anna Marszołek, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 623-623
Open Access | Times Cited: 6

Taking a Swing at TIMP1-Armed Immunosuppressive Astrocytes Unleashes T cell Immunity against Brain Metastases
Mihaela Lorger, Fiona James
Cancer Discovery (2025) Vol. 15, Iss. 1, pp. 11-13
Closed Access

Hybrid Membrane Biomimetic Photothermal Nanorobots for Enhanced Chemodynamic-Chemotherapy-Immunotherapy
Xiaoxia Song, AlSaba Gul, Hongkai Zhao, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access

The immunology of low-grade gliomas
Alexander F. Haddad, Jacob S. Young, Jun Yeop Oh, et al.
Neurosurgical FOCUS (2022) Vol. 52, Iss. 2, pp. E2-E2
Open Access | Times Cited: 34

Multispectral fluorine-19 MRI enables longitudinal and noninvasive monitoring of tumor-associated macrophages
Davide Croci, Rui Santalla Méndez, Sebastian Temme, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 667
Open Access | Times Cited: 33

DC vaccines loaded with glioma cells killed by photodynamic therapy induce Th17 anti-tumor immunity and provide a four-gene signature for glioma prognosis
Maria V. Vedunova, Victoria D. Turubanova, Olga Vershinina, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 12
Open Access | Times Cited: 28

Page 1 - Next Page

Scroll to top